Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ISRCTN10602491) titled 'Study of the efficacy and safety of Dipana(R) in functional gallbladder disorder' on Sept. 30.
Study Type: Observational
Study Design:
Case series
Primary Sponsor: Sentiss Rus LLC
Condition:
Hypomotor-type gallbladder functional disorder
Digestive System
Intervention:
Dipana(R) was administered orally at a dose of one tablet three times daily for 4 weeks.
In accordance with routine clinical practice, data on patient complaints, medical history, and demographics were collected
clinical manifestations of gallbladder dyskinesia were assessed
abdominal ultrasound was performed
and the patients' psycho-emotional...